The Food and Drug Administration’s advisory committee will meet in June to discuss Novavax’s COVID-19 vaccine and Pfizer’s and Moderna’s vaccines for younger children. The companies are completing their submissions for authorization. (CNBC Weekly)

Pfizer vaccine researcher Kathrin Jansen will retire this year. Jansen, who led Pfizer’s COVID-19 vaccine collaboration with BioNTech, helped develop Garasil while working at Merck. (STAT)

AbbVie is dropping its experimental triplet therapy for cystic fibrosis after efficacy results from a Phase II study didn’t meet criteria. The trial had been testing a dual combo therapy alongside C2 corrector ABBV-119. (Endpoints News)

Tens of thousands of people with private Medicare Advantage plans don’t receive necessary care that is supposed to be covered by the program, according to a report. The report called for improved regulation of the private insurance plans. (The New York Times)

The FDA’s proposed menthol ban is dividing Black leaders, some of whom believe it could lead to further over-policing of Black people. The Rev. Al Sharpton noted the ban could come with “unintended consequences.” (Politico)